Actions COVID vaccine makers are taking to tackle variants: Data Byte

COVID-19 vaccine developers are taking multiple approaches to combat emerging SARS-CoV-2 variants, ranging from administering additional booster shots of authorized vaccines to developing variant-specific or multivalent candidates. 

FDA issued guidance this week outlining a streamlined clinical development path for vaccines against new variants based on clinical immunogenicity studies that compare neutralizing antibody titers from new vaccines in COVID-19 vaccine-naïve participants or that study variant vaccines as a booster in previously vaccinated individuals...